🇺🇸 Strattera in United States

12,161 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 1,815 reports (14.92%)
  2. Nausea — 1,442 reports (11.86%)
  3. Fatigue — 1,430 reports (11.76%)
  4. Somnolence — 1,295 reports (10.65%)
  5. Feeling Abnormal — 1,147 reports (9.43%)
  6. Headache — 1,080 reports (8.88%)
  7. Insomnia — 1,021 reports (8.4%)
  8. Vomiting — 1,016 reports (8.35%)
  9. Prescribed Overdose — 973 reports (8%)
  10. Abnormal Behaviour — 942 reports (7.75%)

Source database →

Strattera in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Strattera approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Strattera in United States?

University of Oklahoma is the originator. The local marketing authorisation holder may differ — check the official source linked above.